Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

More selective GABA-A receptor ligands prepared and evaluated at Merck & Co.

Aug. 27, 1999

Australian academic-industrial team identifies improved opioid analgesics

Aug. 27, 1999

Clinical candidate selected from 5-ht6 receptor antagonist program at Roche

Aug. 27, 1999

Aradigm presents data on morphine electronic inhaler at pain congress in Vienna

Aug. 27, 1999

Berlin Chemie launches Sympal in Germany

Aug. 26, 1999

ACS presentation for Parke-Davis's selective NR1a/2B receptor antagonist PD-188669

Aug. 25, 1999

Japan is country of first launch for migraine prevention agent

Aug. 25, 1999

Medco issued patent covering allosteric adenosine modulators

Aug. 25, 1999

Adenosine A1 receptor agonist NNC-21-0147 is a potent neuroprotectant without CV effects

Aug. 24, 1999

ACS research news: Neurocrine Biosciences presents newest CRF antagonist

Aug. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026